1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Acute Lymphoblastic Leukaemia Recurrent: new trials by email Literature Review of Acute Lymphoblastic Leukaemia Recurrent trials Research Report on Acute Lymphoblastic Leukaemia Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients Venetoclax low dose with itraconazole - Acute Lymphobkastic Leukemia, Acute Lymphoblastic Leukaemia Recurrent | Phase 2 | Recruiting | Hospital Universitario Dr. Jose E. Gonzalez | 12 | 2025-01-02 | 2025-10-02 |
| CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic Leukemia CD19 CAR T cells - Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukaemia Recurrent | Phase 1 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 20 | 2016-11-01 | 2025-06-03 |
Leukemia (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Itraconazole (1) · venetoclax (1)
Hospital Universitario Dr. Jose E. Gonzalez (1) · Institute of Hematology & Blood Diseases Hospital, China (1)
China (1) · Mexico (1)